SCHEMBL10014795

SCHEMBL10014795

CCCP(=O)(Oc1ccc(OCc2ccccc2)cc1)Oc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.52
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
MAOB P27338 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NPC1 O15118 1/20 0.50
HPGD P15428 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
NR4A1 P22736 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17460862 0.94 PPARG (0.48) ARHDAC3HDAC1HDAC2NCOR2
SCHEMBL4454035 0.83 L3MBTL1 (0.53) LMNAL3MBTL1KDM4EMEN1KMT2A
SCHEMBL10014793 0.80 LMNA (0.60) MAOBRAB9ASMN1; SMN2NPC1LMNA
SCHEMBL10014794 0.78 LMNA (0.58) MAOBRAB9ASMN1; SMN2NPC1LMNA
SCHEMBL10014796 0.78 LMNA (0.58) MAOBRAB9ASMN1; SMN2NPC1LMNA
SCHEMBL20582562 0.78 LMNA (0.50) ARHDAC3HDAC1HDAC2NCOR2
SCHEMBL5861974 0.77 LMNA (0.61) MAOBRAB9ASMN1; SMN2NPC1LMNA
SCHEMBL5404588 0.76 CETP (0.58) L3MBTL1MEN1KMT2A
SCHEMBL10014792 0.76 LTA4H (0.43) SMN1; SMN2LMNACYP1A2CYP2C19KDM4E
SCHEMBL339813 0.75 LMNA (0.82) MAOBRAB9ASMN1; SMN2LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9243012-B2 Phosphorous containing benzoxazine-based monomer, or polymer thereof SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-01-26 US disclosed
US-20120264909-A1 PHOSPHOROUS CONTAINING BENZOXAZINE-BASED MONOMER, POLYMER THEREOF, ELECTRODE FOR FUEL CELL INCLUDING THE SAME, ELECTROLYTE MEMBRANE FOR FUEL CELL INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-10-18 US disclosed
US-20120264909-A1 PHOSPHOROUS CONTAINING BENZOXAZINE-BASED MONOMER, POLYMER THEREOF, ELECTRODE FOR FUEL CELL INCLUDING THE SAME, ELECTROLYTE MEMBRANE FOR FUEL CELL INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-10-18 US disclosed
US-8192892-B2 Phosphorous containing benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-06-05 US disclosed
US-8192892-B2 Phosphorous containing benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-06-05 US disclosed
US-20090068543-A1 PHOSPHOROUS CONTAINING BENZOXAZINE-BASED MONOMER, POLYMER THEREROF, ELECTRODE FOR FUEL CELL INCLUDING THE SAME, ELECTROLYTE MEMBRANE FOR FUEL CELL INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2009-03-12 US disclosed
US-20090068543-A1 PHOSPHOROUS CONTAINING BENZOXAZINE-BASED MONOMER, POLYMER THEREROF, ELECTRODE FOR FUEL CELL INCLUDING THE SAME, ELECTROLYTE MEMBRANE FOR FUEL CELL INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264909-A1 PHOSPHOROUS CONTAINING BENZOXAZINE-BASED MONOMER, POLYMER THEREOF, ELECTRODE FOR FUEL CELL INCLUDING THE SAME, ELECTROLYTE MEMBRANE FOR FUEL CELL INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE SAME PDK2, PCK1, PDK4 AR 3983/4885HDAC3 4534/4885HDAC1 3560/4885
US-20090068543-A1 PHOSPHOROUS CONTAINING BENZOXAZINE-BASED MONOMER, POLYMER THEREROF, ELECTRODE FOR FUEL CELL INCLUDING THE SAME, ELECTROLYTE MEMBRANE FOR FUEL CELL INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE SAME WEE1, HADHB, PXMP4 AR 4168/4885HDAC3 4466/4885HDAC1 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.